Polo-like Kinase 1 Licenses CENP-A Deposition at Centromeres  by McKinley, Kara L. & Cheeseman, Iain M.
Polo-like Kinase 1 Licenses CENP-A
Deposition at Centromeres
Kara L. McKinley1 and Iain M. Cheeseman1,*
1Whitehead Institute and Department of Biology, MIT, Nine Cambridge Center, Cambridge, MA 02142, USA
*Correspondence: icheese@wi.mit.edu
http://dx.doi.org/10.1016/j.cell.2014.06.016SUMMARY
To ensure the stable transmission of the genome
during vertebrate cell division, the mitotic spindle
must attach to a single locus on each chromosome,
termed the centromere. The fundamental require-
ment for faithful centromere inheritance is the
controlled deposition of the centromere-specifying
histone, CENP-A. However, the regulatory mecha-
nisms that ensure the precise control of CENP-A
deposition have proven elusive. Here, we identify
polo-like kinase 1 (Plk1) as a centromere-localized
regulator required to initiate CENP-A deposition in
human cells. We demonstrate that faithful CENP-A
deposition requires integrated signals from Plk1
and cyclin-dependent kinase (CDK), with Plk1 pro-
moting the localization of the key CENP-A deposition
factor, the Mis18 complex, and CDK inhibiting
Mis18 complex assembly. By bypassing these regu-
lated steps, we uncoupled CENP-A deposition from
cell-cycle progression, resulting in mitotic defects.
Thus, CENP-A deposition is controlled by a two-
step regulatory paradigm comprised of Plk1 and
CDK that is crucial for genomic integrity.
INTRODUCTION
During cell division, the genome must be segregated equally be-
tween the daughter cells. To accomplish this, the mitotic spindle
must attach to each chromosome at a single locus, termed the
centromere. Chromosomes lacking a functional centromere
are unable to attach to the segregation apparatus, resulting in
chromosome loss. In contrast, chromosomes with multiple cen-
tromeres can attach simultaneously to opposing spindle poles,
resulting in chromosome missegregation and DNA damage.
Indeed, chromosomes with multiple centromeres are frequently
observed in cancers and can promote genomic instability and
characteristics of tumorigenesis (Gisselsson et al., 2000; Gas-
coigne and Cheeseman, 2013).
In most eukaryotes, centromeres are specified epigenetically
by the presence of the histone H3 variant, CENP-A (Black
et al., 2010). Thus, centromere inheritance depends on themain-
tenance of CENP-A-containing nucleosomes at a single site on
each chromosome. During DNA replication, existing CENP-A-containing nucleosomes are distributed to the replicated sister
chromatids. Subsequently, CENP-A-containing nucleosomes
must be replenished at centromeres. CENP-A deposition is
restricted both spatially, to existing centromeres, and tempo-
rally, to G1 phase in human cells (Jansen et al., 2007). Current
models suggest that this temporal restriction is crucial for faithful
centromere inheritance and function (Go´mez-Rodrı´guez and
Jansen, 2013). However, the regulatory paradigms that control
the propagation of this crucial epigenetic mark remain poorly
understood.
The restriction of CENP-A deposition is accomplished at least
in part through the regulated recruitment and function of its dedi-
cated deposition machinery. In human cells, CENP-A incorpora-
tion is carried out by at least two sets of factors: the Mis18 com-
plex, which assembles from Mis18a, Mis18b, and M18BP1/
KNL2 (Hayashi et al., 2004; Fujita et al., 2007; Maddox et al.,
2007), and the CENP-A chaperone, HJURP (Dunleavy et al.,
2009; Foltz et al., 2009). The full Mis18 complex localizes to
centromeres beginning at anaphase onset (Hayashi et al.,
2004; Fujita et al., 2007; Maddox et al., 2007; Figure 1A). HJURP
recruitment and new CENP-A deposition then occur during G1
(Jansen et al., 2007; Dunleavy et al., 2009; Foltz et al., 2009; Fig-
ure 1A). Recent work demonstrated that cyclin-dependent
kinase 1 and 2 (CDK1 and CDK2) negatively regulate CENP-A
deposition to restrict this process to G1 (Silva et al., 2012). How-
ever, thus far, it has not been possible to uncouple CENP-A
deposition from its temporal regulation without also disrupting
cell cycle progression (Silva et al., 2012). This suggests that
key mechanistic steps or regulatory paradigms for the control
of CENP-A deposition remain to be defined.
We sought to determine the molecular basis for the regulation
of CENP-A deposition. Our data establish a regulatory paradigm
for CENP-A deposition that combines global regulation by CDK
and a centromere-localized initiation signal provided by polo-like
kinase 1 (Plk1). Defining themechanisms bywhich Plk1 and CDK
control CENP-A deposition allowed us to bypass the cell cycle
regulation of CENP-A deposition, resulting in severe mitotic de-
fects. Thus, the regulation of CENP-A deposition downstream of
Plk1 and CDK is critical to protect the integrity of the genome.
RESULTS
Plk1 Displays Mis18 Complex-Dependent Localization
to G1 Centromeres
To identify potential factors that regulate CENP-A deposition,
we began by isolating GFP-Mis18a by affinity purification fromCell 158, 397–411, July 17, 2014 ª2014 Elsevier Inc. 397
Figure 1. Plk1 Localizes to G1 Centromeres in a Mis18 Complex-Dependent Manner
(A) Images showing the localizationof componentsof theCENP-Adepositionpathway inanaphaseandG1.Time-lapse imagesof singlecells are shown forMis18a,
Mis18b, M18BP1, and HJURP. New CENP-A-SNAP was labeled with SNAP-Cell TMR-Star using a quench-pulse strategy (Jansen et al., 2007) in fixed cells.
(B) Schematic describing the isolation of G1 samples of GFP-Mis18a cells for analysis by mass spectrometry.
(C) Summary of mass spectrometry results following immunoprecipitation of GFP-Mis18a. Proteins shown are those identified in the GFP-Mis18a immuno-
precipitation, but not in unrelated immunoprecipitations of other GFP-tagged proteins. AS, asynchronous sample generated from cells that failed to arrest in
nocodazole.
(D) G1 localization of Plk1 tagged with YFP at the endogenous locus. Centromeres are marked with anti-centromere antibodies.
(E) Immunofluorescence images showing YFP-Plk1 localization in Mis18-complex-depleted cells (with g adjustment). Centromeres are identified using anti-
centromere antibodies.
(F) Time-lapse images of YFP-Plk1 in Mis18a-depleted cells. Numbers represent minutes after the metaphase image. Panels are not scaled equivalently but are
scaled (with g adjustment) to show the full range of data.
Scale bars, 5 mm. See also Figure S1 and Tables S1, S2, S3, S4, and S5.HeLa cells that were synchronized by mitotic shake off and
then allowed to progress into G1 (Figure 1B). Mass spectrometry
analysis identified the established components of the Mis18
complex—Mis18a, Mis18b, and M18BP1 (Figure 1C). In addi-
tion, we found that Plk1 copurified with the Mis18 complex (Fig-
ure 1C). The isolation of Plk1 with the Mis18 complex from G1
cells was unexpected, as Plk1 has been described predomi-
nantly as an M phase kinase (Barr et al., 2004). To assess the398 Cell 158, 397–411, July 17, 2014 ª2014 Elsevier Inc.relevance of the association between the Mis18 complex and
Plk1, we analyzed HeLa cells stably expressing yellow fluores-
cent protein (YFP)-Plk1. Prior work focused on the localization
of Plk1 to centrosomes, mitotic kinetochores, the spindle mid-
zone, and the midbody (Archambault and Glover, 2009). In addi-
tion, as reported by others (Arnaud et al., 1998; Kishi et al.,
2009), we found that YFP-Plk1 localized to centromeres in G1,
concurrent with Mis18a localization (Figure S1A available
online). We observed identical localization when we tagged
the endogenous PLK1 locus with YFP using CRISPR/Cas-medi-
ated genome editing (Plk1-YFP) (Figure 1D). In contrast, the
related polo-like kinases, Plk2 and Plk3, did not localize to
G1 centromeres (Figure S1B). Depletion of Mis18a or M18BP1
by RNAi abolished Plk1 localization to G1 centromeres (Figures
1E, 1F, S1C, and S1D). In contrast, Plk1 localization to the
spindle midzone, midbody, and mitotic kinetochores was
unaffected by Mis18a or M18BP1 depletion (Figures 1E, 1F,
and S1C; data not shown). These observations indicate that
Plk1 localizes to G1 centromeres in a Mis18 complex-depen-
dent manner.
Plk1 Activity Is Required for New CENP-A Deposition
The copurification of Plk1 with the Mis18 complex and the
localization of Plk1 to G1 centromeres suggested that Plk1might
contribute to CENP-A deposition. To test this, we inhibited Plk1
kinase activity using the small molecule BI2536 (Le´na´rt et al.,
2007; Steegmaier et al., 2007) and assessed the incorporation
of new CENP-A using a CENP-A-SNAP quench-pulse assay
(Jansen et al., 2007; Figure 2A). We observed a dramatic defect
in the deposition of new CENP-A following BI2536 treatment
(Figures 2A and S2A). We also observed a reduction in new
CENP-A incorporation following treatment with the bulky ATP
analog 3MB-PP1 in an RPE1 cell line expressing an analog-sen-
sitive allele of Plk1 (Plk1as) (Burkard et al., 2007; Figure S2B).
These data indicate that Plk1 activity is required for CENP-A
deposition.
In human cells, CENP-A deposition is restricted to the G1
phase of the cell cycle (Jansen et al., 2007). As Plk1 plays an
established role in cell-cycle progression (Barr et al., 2004), we
sought to test whether the observed defects in CENP-A deposi-
tion were due to global effects of Plk1 inhibition on cell state.
However, the BI2536-treated cells with a G1-like morphology
that we analyzed for our experiments displayed cell-cycle
markers consistent with an unperturbed G1 state, including
increasing levels of nuclear Cdt1-RFP, minimal levels of gemi-
nin-GFP (Sakaue-Sawano et al., 2008), diffuse PCNA staining,
and low cyclin B1 levels (Figures S2C and S2D). This suggests
that Plk1 regulates CENP-A deposition independently of its pre-
viously reported effects on cell-cycle progression.
Recent work demonstrated that CENP-A deposition can be
induced in S and G2 cells following the inhibition of CDK (Silva
et al., 2012). As we also observed Plk1 localization to centro-
meres during S phase and G2 (Figure S2E), we tested whether
CENP-A incorporation following CDK inhibition depended on
Plk1. Treatment with BI2536 severely disrupted CENP-A deposi-
tion in G2 cells following CDK inhibition (Figure 2B). These data
indicate that Plk1-dependent regulation of new CENP-A deposi-
tion does not depend on residual CDK activity or regulatory
circuits and events that are specific to mitotic exit, such as cyto-
kinesis (Petronczki et al., 2007).
Previous work found that newly deposited CENP-A must be
actively maintained by a process involving MgcRacGAP (Lagana
et al., 2010), which is also a substrate of Plk1 (Wolfe et al., 2009).
Therefore, we sought to test whether Plk1 was required to main-
tain new CENP-A at centromeres. To this end, we allowed
cells with fluorescently labeled new CENP-A-SNAP to progressthrough G1 for 2.5 hr before the addition of BI2536. In this
assay, we found that newly deposited CENP-A remained intact
following BI2536 treatment (Figure 2C). In contrast, ongoing
CENP-A deposition was halted following Plk1 inhibition (Fig-
ure 2C). This suggests that Plk1 is continuously required to direct
CENP-A deposition but that it is not required to maintain newly
incorporated CENP-A.
The Mis18 Complex and HJURP, but Not CENP-C,
Require Plk1 Activity for Proper Localization to G1
Centromeres
We next sought to determine the mechanisms by which Plk1
promotes CENP-A incorporation. As a first step, we assessed
the functional contributions of Plk1 to each step in the CENP-
A deposition process. Previous work implicated the constitutive
centromere protein CENP-C as a centromere-localized binding
partner for the Mis18 complex (Moree et al., 2011; Dambacher
et al., 2012). However, the functional contribution of CENP-C to
Mis18 complex recruitment in mammalian cells has remained
unclear (Dambacher et al., 2012). Therefore, we analyzed
Mis18 complex localization following depletion of CENP-C by
RNAi. As CENP-C depletion causes a mitotic arrest, we drove
cells into G1 using an inhibitor of the checkpoint kinase Mps1.
We found that depletion of CENP-C, but not the constitutive
centromere protein CENP-T, strongly reduced Mis18 com-
plex localization to G1 centromeres (Figure 3A), indicating
that CENP-C is required for Mis18 complex recruitment. How-
ever, treatment with the Plk1 inhibitor BI2536 did not affect
CENP-C localization (Figure 3B), indicating that Plk1 inhibition
does not result in the global destabilization of interphase
centromeres.
We next tested the contribution of Plk1 to Mis18 complex
localization. BI2536-treated cells displayed a substantial
decrease in GFP-M18BP1 and mCherry- or GFP-Mis18a locali-
zation to G1 centromeres (Figures 3C and 3D), indicating that
Plk1 activity is required for robust Mis18 complex localization.
In addition to localizing to G1 centromeres, we found that
GFP-M18BP1 localized to centromeres throughout mitosis (Fig-
ures S3A and S3B), consistent with previous reports for Xenopus
laevis M18BP1 localization (Moree et al., 2011). Therefore, we
also tested the effects of Plk1 inhibition on GFP-M18BP1 local-
ization in both prometaphase and an anaphase-like state
induced by CDK inhibition. In contrast to the defects observed
in G1 cells (Figures 3C and 3F; t = 60 min after CDK inhibition),
the prometaphase (Figure 3E) and anaphase-like (Figure 3F; t =
10 min after CDK inhibition) localization of M18BP1 was unaf-
fected by Plk1 inhibition. Taken together, these data indicate
that Plk1 is required to maintain the localization of the Mis18
complex at centromeres specifically during G1, the period
when CENP-A deposition occurs.
Finally, we analyzed the effect of Plk1 inhibition on the
centromere localization of the CENP-A chaperone, HJURP.
Consistent with the defects in CENP-A deposition and Mis18
complex localization described above, BI2536-treated cells
exhibited striking defects in the centromere localization of
GFP-HJURP (Figure 3G). These data indicate that Plk1 activity
is required for multiple aspects of the CENP-A deposition
process.Cell 158, 397–411, July 17, 2014 ª2014 Elsevier Inc. 399
Figure 2. Plk1 Activity Is Required for New CENP-A Deposition
(A) Top: schematic of the cell synchronization and CENP-A-SNAP labeling strategy to detect the deposition of newly synthesized CENP-A using a fluorescent
quench-pulse strategy (Jansen et al., 2007). Mitotic cells were harvested and allowed to progress through G1 in the presence of BI2536 or DMSO for 2.5 hr before
staining. Bottom: immunofluorescence images showing incorporation of new CENP-A-SNAP (labeled with SNAP-Cell Oregon Green) following treatment
with BI2536 or DMSO. Centromeres are identified using anti-centromere antibodies. The microtubule morphology observed following BI2536 treatment is
characteristic of failed cytokinesis due to Plk1 inhibition. Numbers represent CENP-A-SNAP centromeric fluorescence intensity as percent of control ± SEM;
p < 0.001 (Student’s t test); n = 20 G1 cell pairs.
(B) Top: schematic of the cell synchronization and CENP-A-SNAP labeling strategy used to test the Plk1 dependence of new CENP-A deposition in G2 phase
following inhibition of CDK by flavopiridol (CDKi). Bottom: immunofluorescence images showing incorporation of new CENP-A-SNAP (labeled with SNAP-Cell
TMR-Star) following treatment with BI2536 or DMSO and CDK inhibition. Centromeres are identified using anti-centromere antibodies. Numbers represent
CENP-A-SNAP centromeric fluorescence intensity as percent of control ± SEM; p < 0.001 (Student’s t test); n = 20 cyclin Bhigh cells.
(C) Top: schematic of the cell synchronization and CENP-A-SNAP labeling strategy used to test whether the maintenance of newly deposited CENP-A
depends on Plk1. Bottom: quantification of centromeric fluorescence intensity of new CENP-A-SNAP (labeled with SNAP-Cell Oregon Green) as percent of levels
at 2.5 hr ± SEM; n = 20 G1 cell pairs per condition per time point.
Scale bars, 5 mm. See also Figure S2.
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The Mis18 Complex Is a Key Target of Plk1 during
CENP-A Deposition
To define the direct targets of Plk1, we performed in vitro kinase
assays using recombinant components of the CENP-A deposi-
tion machinery. For these assays, we reconstituted the full
Mis18 complex by coexpression of its subunits in bacteria (Fig-
ure S4A). Plk1 directly phosphorylated theMis18 complex based
on radioactive kinase assays (Figures 4A and S4B) and mass
spectrometry analysis of in vitro phosphorylated samples (Fig-
ure S4C). In contrast, Plk1 did not efficiently phosphorylate
HJURP or a C-terminal region of CENP-C containing the
M18BP1-binding region (Moree et al., 2011; Dambacher et al.,
2012) that we found to be necessary and sufficient for Mis18
complex recruitment (Figures 3A and 4A). These data suggest
that the Mis18 complex is a major target of Plk1 in the CENP-A
deposition pathway.
A subset of the phosphorylation sites in theMis18 complex that
we mapped in vitro has also been identified by mass spectrom-
etry analysis of endogenous samples (Dephoure et al., 2008;
Shiromizu et al., 2013; Figure S4C). To directly test whether the
Mis18 complex is a substrate of Plk1 in vivo, we generated an
antibody specific to phospho-T702 on M18BP1 (Figure S4D).
This antibody detected centromeres by immunofluorescence
in control cells, but not following M18BP1 RNAi (Figures 4B and
S4E). Treatment with BI2536 abolished this signal (data not
shown). However, it remained possible that the signal was elimi-
nated because BI2536 treatment also causes Mis18 complex
delocalization (Figure 3). To overcome this, we uncoupled
Mis18 complex localization from Plk1 activity by generating an
in-frame fusion between M18BP1 and the C-terminal domain of
CENP-Cdescribed above (CENP-C-M18BP1) (Figure 4C). Local-
ization of the CENP-C-M18BP1 fusion was unaffected by Plk1
inhibition (Figure 4D), consistentwith thePlk1-independent local-
ization of CENP-C (Figure 3B). Despite the continued localization
of the CENP-C-M18BP1 fusion, the pT702 signal at centromeres
was eliminated following BI2536 treatment (Figures 4E and 4F).
Collectively, thesedata suggest thatPlk1directly phosphorylates
the Mis18 complex in vitro and in cells.
Plk1 binds to many of its substrates via a phosphopeptide-
binding module termed the polo-box domain (PBD) (Elia et al.,
2003a). Therefore, we sought to determine if the Mis18 complex
and the Plk1 PBD interact directly. Substrates are primed
to interact with the PBD by kinases including CDK (Elia et al.,
2003a) and Plk1 itself (known as self-priming; Burkard et al.,
2007; Neef et al., 2007). We found that glutathione S-transferase
(GST)-PBD bound robustly to the recombinant Mis18 complex
by far-western analysis but only when the Mis18 complex had
been previously phosphorylated with Plk1 (Figure 4G). Consis-
tent with a Plk1 phosphorylation-dependent interaction between
the Mis18 complex and the Plk1 PBD, we found that Plk1 local-
ization to G1 centromeres required both a functional PBD and
Plk1 kinase activity (Figure 4H). Therefore, Plk1 can phosphory-
late and bind to the Mis18 complex directly via its PBD.
Plk1 Phosphorylation of the Mis18 Complex Promotes
New CENP-A Deposition
To test the consequences of Mis18 complex phosphorylation by
Plk1, we generated cell lines expressing RNAi-resistant versionsof M18BP1, Mis18a, or Mis18b. Wild-type versions of these con-
structs were functional to carry out CENP-A deposition in the
absence of the corresponding endogenous proteins (Figures
5A, and 5B, and S5A). We next generated mutants in which the
mapped Plk1 phosphorylation sites were mutated to alanine to
prevent their phosphorylation (Plk1-A mutants; see Table S2).
In the presence of the endogenous proteins, these mutants dis-
played wild-type localization (data not shown), suggesting that
these mutations do not substantially disrupt the structural integ-
rity of these proteins.
Todetermine the importanceof thesephosphorylated residues
for CENP-A deposition, we tested CENP-A incorporation in the
mutant cell lines following depletion of the endogenous proteins
by RNAi. Cells expressing mCherry-Mis18aPlk1-A, Mis18bPlk1-A-
GFP, or coexpressing Mis18aPlk1-A and Mis18bPlk1-A did not
display defects in new CENP-A deposition following depletion
of their endogenous counterparts (Figure S5A). In contrast, cells
expressing GFP-M18BP1Plk1-A displayed severe defects in new
CENP-A-SNAP incorporation following depletion of endogenous
M18BP1 (Figures 5A and 5B). We attempted to mimic Plk1
phosphorylation by mutating the Plk1 phosphorylation sites
to aspartate (GFP-M18BP1Plk1-D). However, GFP-M18BP1Plk1-D
displayed similar defects in CENP-A deposition as GFP-
M18BP1Plk1-A (Figure S5B). We speculate that aspartate does
not effectively mimic the phosphate group in this context and
thus renders the mutant nonfunctional. These data indicate
that Plk1 phosphorylation of M18BP1 is required for CENP-A
deposition.
In the absence of endogenous M18BP1, we also observed
a significant reduction in the levels of GFP-M18BP1Plk1-A at
centromeres (Figures 5A and 5C). To test whether the defect in
M18BP1Plk1-A localization was caused by a global decrease in
the levels of kinetochore proteins due to defective CENP-A
deposition, we tested the effect of directly depleting CENP-A
by RNAi on GFP-M18BP1Plk1-A localization (Figures S5C
and S5D). CENP-A depletion had a minimal effect on GFP-
M18BP1Plk1-A levels (Figure S5D), consistent with previous
reports demonstrating a limited reduction in CENP-C levels
at a similar time point following induction of a conditional
CENP-A knockout (Fachinetti et al., 2013). This suggests that
the observed reduction in M18BP1Plk1-A localization is due
to a defect intrinsic to the mutant. Collectively, these data
demonstrate that direct phosphorylation of the Mis18 com-
plex by Plk1 promotes M18BP1 localization and new CENP-A
deposition.
The identified Plk1 phosphorylation sites in M18BP1 are
present throughout the protein (Figure 5D). We found that
an N-terminal (NT) region (amino acids 1–490; M18BP1-NT)
was sufficient for M18BP1 centromere localization and Mis18a
recruitment (Figures S5E and S5F) and was functional to restore
CENP-A deposition to M18BP1-depleted cells (Figures 5E and
5F). Therefore, we tested the requirements for the Plk1 phos-
phorylation sites that we identified in this region (GFP-
M18BP1Plk1-A-NT; Figure 5D). GFP-M18BP1-NT showed
robust centromere localization in the presence and absence
of endogenous M18BP1 (Figures 5E and 5G). In contrast, GFP-
M18BP1Plk1-A-NT localized weakly to centromeres in the
presence of the endogenous protein (Figure S5G), and thisCell 158, 397–411, July 17, 2014 ª2014 Elsevier Inc. 401
Figure 3. Plk1 Is Required for the Localization of the Mis18 Complex and HJURP to G1 Centromeres
(A) Live-cell images of GFP-Mis18a cells following 48 hr treatment with siRNAs against the indicated targets. Penetrant RNAi was confirmed by observation of a
disorganized metaphase plate before cells were driven into G1 using an Mps1 inhibitor (Mps1i; AZ3146) for 1 hr. The Mis18a recruitment defect observed in
CENP-CRNAi can be rescued by expression of the RNAi-resistant CENP-CC terminus (CT: amino acids 510–934). Right: depletion of the constitutive centromere
protein CENP-T does not affect Mis18a localization.
(B) Immunofluorescence images showing localization of CENP-C following treatment with DMSO or BI2536. Numbers represent centromeric fluorescence
intensity as percent of control ± SEM; n = 20 G1 cell pairs; p > 0.05 (Student’s t test).
(C) Immunofluorescence images showing GFP-Mis18a localization following treatment with BI2536 or DMSO. Numbers represent centromeric fluorescence
intensity as percent of control ± SEM; n = 20 G1 cell pairs; p < 0.001 (Student’s t test).
(legend continued on next page)
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localization was further reduced upon depletion of endogenous
M18BP1 (Figures 5E and 5G). In addition, CENP-A deposition
was severely defective in cells expressing GFP-M18BP1Plk1-A-
NT following M18BP1 RNAi (Figures 5E and 5F). These data indi-
cate that Plk1 phosphorylation of the N terminus of M18BP1 is
critical for M18BP1 localization and function.
The phenotypes observed in the M18BP1Plk1-A mutant sug-
gest that Plk1 phosphorylation of M18BP1 promotes its locali-
zation and new CENP-A incorporation. To distinguish whether
the primary function of Plk1 during CENP-A deposition is to
regulate M18BP1 localization, we bypassed the regulated
M18BP1 localization using the CENP-C-M18BP1 fusion. As
described above, in the absence of the CENP-C fusion partner,
M18BP1Plk1-A displayed severely defective CENP-A deposition
following M18BP1 depletion (Figures 5A and 5B). In contrast,
CENP-C-M18BP1Plk1-A partially restored CENP-A deposition to
M18BP1-depleted cells (Figure S5H), although to a lesser extent
than wild-type CENP-C-M18BP1. This suggests that Plk1 phos-
phorylation of M18BP1 primarily affects CENP-A deposition by
modulating M18BP1 localization.
Cyclin-Dependent Kinase Regulates Mis18 Complex
Assembly
The combination of these data demonstrates that Plk1 acts as a
key regulator for CENP-A deposition and functions at least in part
throughmodulatingM18BP1 localization. Previouswork demon-
strated that CDK1/CDK2 activity inhibits CENP-A deposition
(Silva et al., 2012).We therefore sought to define themechanisms
by which these two kinases coordinately regulate the CENP-A
deposition process. CDK has been proposed to act by restricting
M18BP1 localization to anaphase and G1 (Silva et al., 2012).
However, when we mutated the full complement of serine and
threonine residues corresponding to CDK consensus phosphor-
ylation sites to alanine (GFP-M18BP1CDK-A; Table S2), we found
that this mutant displayed similar temporal localization to wild-
type GFP-M18BP1, localizing to centromeres from mitotic entry
through G1 (data not shown). In contrast, Mis18a and Mis18b
did not localize until anaphase onset (Figures S3A and 1A),
suggesting that assembly of the Mis18 complex is cell cycle
regulated.
To test whether CDK controls the recruitment of Mis18a and
Mis18b, we next used the CENP-C-M18BP1 fusion, which local-
izes to centromeres constitutively (Figure S6A). Despite the
constitutive localization of CENP-C-M18BP1, Mis18a localiza-(D) Time-lapse images of live cells coexpressing GFP-M18BP1 and mCherry-M
anaphase. Numbers indicate minutes after BI2536 addition.
(E) Quantification of centromeric GFP-M18BP1 levels in live prometaphase-like c
STLC for 4 hr to induce a mitotic arrest before addition of BI2536 or DMSO for
rescence ± SEM; n = 10 cells. NS, not significant; p > 0.05 (Student’s t test).
(F) Quantification of centromeric GFP-M18BP1 levels in live cells following treat
function of the drug, cells were pretreated with BI2536 for 1 hr. As a control, ce
monopolar spindle. To bypass the arrest, mitotic exit was induced with the CDK
inhibition were chosen to correspond to anaphase (10 min) and G1 (60 min). Num
SEM; n = 10 cells. ***p < 0.001 (Student’s t test).
(G) Immunofluorescence images showing localization of GFP-HJURP followin
centromere antibodies. The images are not scaled equivalently but are scaled to
intensity as percent of control ± SEM; n = 20 G1 cell pairs; p < 0.001 (Student’s
Scale bars, 5 mm. See also Figure S3.tion remained restricted to anaphase/G1 in cells expressing
this fusion (Figure S6A). In contrast, expression of a fusion
between the CENP-C C-terminal domain and M18BP1CDK-A
(CENP-C-M18BP1CDK-A) resulted in premature GFP-Mis18a
recruitment (Figure 6A). These data indicate that the CDK-
dependent inhibition of CENP-A deposition occurs at least
in part through preventing assembly of the Mis18 complex at
centromeres.
We next sought to determine whether Plk1 and CDK regulate
separate aspects of the CENP-A deposition pathway. Premature
mitotic recruitment of Mis18a in cells expressing CENP-C-
M18BP1CDK-A was not affected by BI2536 treatment or mutation
of the Plk1 phosphorylation sites in M18BP1 alongside the CDK
sites (CENP-C-M18BP1CDK-A-Plk1-A; Table S2; Figures S6B and
S6C). Thus, Plk1 is not required for the assembly of the Mis18
complex. Overall, our data suggest that Plk1 and CDK control
distinct steps in the CENP-A deposition process, with CDK regu-
lating Mis18 complex assembly and Plk1 regulating M18BP1
localization.
The Cell-Cycle Restriction of CENP-A Deposition Is
Crucial for Genomic Integrity
The results above define key regulatory steps for the control of
the CENP-A deposition process downstream of Plk1 and CDK.
To determine if additional regulatory steps are required to pro-
mote CENP-A deposition, we sought to bypass these steps
and uncouple CENP-A deposition from its normal cell cycle re-
striction. Although cells expressing the CENP-C-M18BP1CDK-A
fusion recruit Mis18a to mitotic centromeres, we did not observe
new CENP-A deposition during mitosis at the expression levels
tested (Figures 6B and 6C). As our work suggested that Plk1
and CDK both regulate steps upstream of Mis18a recruitment,
we directly targeted Mis18a to centromeres. Strikingly, in cells
expressing a fusion between the CENP-C C-terminal domain
and Mis18a (CENP-C-Mis18a), we observed newly deposited
CENP-A-SNAP at centromeres in S, G2, and M phase cells
(Figures 6B–6D and S6D).
To determinewhether CENP-A deposition is actively occurring
throughout the cell cycle in cells expressing the CENP-C-Mis18a
fusion, we analyzed the localization of the CENP-A chaperone,
HJURP. In wild-type cells, HJURP recruitment is restricted to
G1 phase, concurrent with CENP-A deposition (Figures 1A and
6E). In contrast, we observed HJURP localization to centromeres
in S, G2, and M phase cells expressing the CENP-C-Mis18ais18a following treatment with BI2536 or DMSO. BI2536 was added in early
ells following treatment with BI2536. Cells were treated with the Eg5 inhibitor
1 hr. Numbers are presented as fold enrichment over initial centromeric fluo-
ment with BI2536. To avoid confounding effects due to delays in uptake and
lls were treated with STLC, which, like BI2536, induces a mitotic arrest with
inhibitor flavopiridol for both BI2536- and STLC-treated cells. Times after CDK
bers are presented as fold increase over centromeric fluorescence at t = 0 ±
g treatment with BI2536 or DMSO. Centromeres are identified using anti-
show the full range of the data. Numbers represent centromeric fluorescent
t test).
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fusion (Figure 6E). This suggests that CENP-C-Mis18a-express-
ing cells incorporate new CENP-A throughout the cell cycle. To
test whether CENP-C-Mis18a expression bypasses the require-
ment for Plk1, we treated cells with BI2536 immediately following
the quenching of existing CENP-A-SNAP with nonfluorescent
substrate and allowed cells to progress through S phase in the
presence of the inhibitor. In CENP-C-Mis18a-expressing cells,
CENP-A deposition continued following BI2536 treatment (Fig-
ure 6F), indicating that Plk1 acts upstream of Mis18a localization
to control CENP-A deposition.
To test the consequences of uncoupling CENP-A incorpora-
tion from its cell cycle regulation, we analyzed the behavior of
mitotic cells expressing the CENP-C-Mis18a fusion. Intriguingly,
cells expressing the CENP-C-Mis18a fusion exhibited severe
mitotic defects including dramatically misaligned chromosomes
and multipolar spindles (Figures 6G and 6H). These phenotypes
are consistent with defective centromere and kinetochore
function. In contrast, cells expressing the CENP-C C-terminal
fragment alone displayed infrequent mitotic defects (Figure 6H).
These data suggest that the precise control of CENP-A deposi-
tion downstream of CDK and Plk1 is critical for proper chromo-
some segregation and genomic integrity.
DISCUSSION
A key goal of the ongoing research in centromere biology has
been to define the epigenetic mechanisms that direct the
sequence-independent propagation of centromeres. However,
the regulatory mechanisms that ensure proper centromere in-
heritance have remained elusive. Recent work demonstrated
that CDK contributes to the cell-cycle restriction of centromere
inheritance by globally inhibiting CENP-A deposition (Silva
et al., 2012). Here, we defined the requirement for a positive,
centromere-localized regulatory signal provided by Plk1 to
initiate CENP-A deposition (Figure 7). This dual control of
CENP-A deposition—combining global CDK regulation with a
site-specific licensing kinase—is analogous to the paradigms
that ensure the fidelity of other key cell cycle events. For
example, although cellular changes in CDK activity are required
to restrict DNA replication and centriole duplication to specific
windows of the cell cycle, the initiation of these processes
requires the licensing kinase Dbf4-dependent kinase to act atFigure 4. Plk1 Binds to and Phosphorylates the Mis18 Complex
(A) Autoradiogram showing Plk1 phosphorylation of recombinant proteins in th
migration of each protein is indicated on the right based on GelCode Blue staini
(B) Immunofluorescence images of G1 cells expressing GFP-Mis18a, costained
(C) Schematic of the CENP-C-M18BP1 fusion used to bypass regulated M18BP
(D) Quantification of mCherry-CENP-C-M18BP1 levels following treatment with B
populations were depleted for endogenous M18BP1. The error bars represent S
(E) Immunofluorescence images showing CENP-C-M18BP1-expressing cells sta
identified with a-CENP-A antibody.
(F) Quantification of pT702 centromeric fluorescence in CENP-C-M18BP1-expre
error bars represent SEM; n = 20 G1 cell pairs; ***p < 0.001 (Student’s t test).
(G) Far-western analysis of recombinant GST-PBD binding to the recombinant M
(H) Left: schematic of modified GFP-Plk1 constructs. Right: immunofluorescence
truncation + nuclear localization signal), FL PBD dead (full-length protein withmuta
FL + BI2536 (full-length protein after treatment with the Plk1 inhibitor BI2536). Im
Scale bars, 5 mm. See also Figure S4.replication origins (Bell and Dutta, 2002) or Plk4 to act at cen-
trioles (Nigg, 2007).
To precisely define the roles for Plk1 and CDK in CENP-A
deposition, we dissected the regulation of each step in the
CENP-A deposition process. In particular, we analyzed three
key points of regulation: (1) M18BP1 localization to centromeres,
(2) Mis18 complex assembly, and (3) new CENP-A deposition by
the CENP-A chaperone HJURP. We found that Plk1 is required
for CENP-A deposition downstream of CENP-C localization
but upstream of Mis18a recruitment. Further, we defined the
Mis18 complex as a direct substrate of Plk1 and demonstrated
that Plk1 phosphorylation of M18BP1 promotes its localization
and CENP-A deposition. These data indicate that M18BP1 is a
key functional target of Plk1. We cannot exclude the possibility
that Plk1 phosphorylation of other components of the CENP-A
deposition pathway contributes to CENP-A incorporation. How-
ever, as the CENP-C-Mis18a fusion bypasses the requirement
for Plk1 to promote CENP-A deposition, Plk1 phosphorylation
of HJURP or MgcRacGAP, which function downstream of
Mis18a localization (Lagana et al., 2010; Barnhart et al., 2011),
is unlikely to play a critical role. In addition, although our data
suggest that Plk1 phosphorylation controls CENP-A deposition
primarily by regulating M18BP1 localization, artificial targeting
of M18BP1 to centromeres as a CENP-C fusion does not fully
bypass the requirement for Plk1 activity. In particular, we find
that the CENP-C-M18BP1Plk1-A fusion does not fully restore
CENP-A deposition in the absence of endogenous M18BP1.
Thus, the phosphorylation sites in M18BP1 may regulate
aspects of M18BP1 function in addition to controlling its
localization.
In addition to identifying Plk1 as a regulator of M18BP1 local-
ization, we also demonstrated that the assembly of the Mis18
complex is regulated by CDK. However, our data indicate that
Plk1 and CDK act independently to control distinct steps during
this process. For example, the regulation of M18BP1 localiza-
tion by Plk1 does not require CDK activity, and regulation
of Mis18 complex assembly by CDK does not require Plk1
phosphorylation. Thus, CENP-A deposition is accomplished by
a two-step regulatory mechanism integrating critical signals
from Plk1 and CDK. Together, these regulators provide the tem-
poral and spatial cues to precisely control CENP-A deposition
(Figure 7).e CENP-A deposition pathway in the presence of 32P-ATP. The approximate
ng (see Figure S4B).
with a-M18BP1 pT702. Centromeres are marked with a-CENP-A antibodies.
1 localization. Numbers represent amino acid positions within CENP-C.
I2536 or DMSO as percent of DMSO levels. Both DMSO and BI2536-treated
EM; n = 20 G1 cell pairs.
ined for a-M1B81P pT702 following treatment with BI2536. Centromeres are
ssing cells following treatment with BI25356 (quantification of Figure 4E). The
is18 complex in the presence or absence of Plk1.
images showing localization of modified GFP-Plk1 constructs: PBD alone (PBD
tions rendering the polo-box unable to bind to its substrates; Elia et al., 2003b),
ages are scaled with g adjustment.
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Figure 5. Plk1 Phosphorylation of the Mis18 Complex Is Required for CENP-A Deposition
(A) Immunofluorescence images showing new CENP-A-SNAP deposition in cells expressing GFP fusions of either M18BP1WT or M18BP1Plk1-A following
treatment with the indicated siRNAs. New CENP-A-SNAP is labeled using SNAP-Cell TMR-Star.
(B) Quantification of centromeric fluorescence intensity of new CENP-A-SNAP following replacement of endogenous M18BP1 with RNAi-resistant GFP-
M18BP1WT or GFP-M18BP1Plk1-A. Numbers are presented as a percentage of the intensity in M18BP1WT cells + control RNAi. The error bars represent SEM;
n = 20 G1 cell pairs. ***p < 0.001 (Student’s t test). Wild-type and mutant cell lines were generated from the same parental CENP-A-SNAP cell line (see Table S1)
and after generation continue to have equivalent levels of total CENP-A-SNAP protein (data not shown). WT, wild-type.
(C) Quantification of centromeric GFP-M18BP1WT or GFP-M18BP1Plk1-A fluorescence intensity in cells in which M18BP1 has been depleted. The error bars
represent SEM; n = 20 G1 cell pairs. ***p < 0.001 (Student’s t test).
(legend continued on next page)
406 Cell 158, 397–411, July 17, 2014 ª2014 Elsevier Inc.
Underlying the efforts to define the mechanisms that regulate
CENP-Adeposition is the assumption that the observedcell cycle
restriction of this process is functionally important for the propa-
gation or function of this epigenetic mark. By defining the key
molecular events required for CENP-A deposition and their regu-
lation,wedeveloped a strategy to bypass the cell cycle regulation
of this process.We found that bypassingPlk1andCDK regulation
by expression of a CENP-C-Mis18a fusion induced CENP-A
deposition throughout the cell cycle, resulting in severe mitotic
defects. This indicates that the precise regulation of CENP-A
deposition by Plk1 and CDK is crucial for proper chromosome
segregation. These data raise exciting new questions regarding
the molecular consequences of uncoupling CENP-A deposition
from cell cycle progression. For example, CENP-A deposition
during S phase alongside canonical H3 may disrupt centromere
integrity or mitotic CENP-A deposition could destabilize chromo-
somecondensationat centromeres.OngoingCENP-Adeposition
during mitosis may also affect kinetochore assembly, either by
preventing the recruitment of key kinetochore components or
by generating additional sites for kinetochore formation and
thereby disrupting the higher-order organization of the kineto-
chore. Together, our data define key roles for Plk1 and CDK in
regulating CENP-A deposition and establish the vital importance
of this regulation for ensuring genomic integrity.
EXPERIMENTAL PROCEDURES
Cell Culture
HeLa cell lines were cultured in Dulbecco’s modified Eagle medium (DMEM)
supplemented with 10% fetal bovine serum (FBS), penicillin/streptomycin,
and 2 mM L-glutamine. hTERT-RPE1 Plk1as cells were maintained in
DMEM:F12 with 10% FBS, penicillin/streptomycin, and 2 mM L-glutamine.
For time-lapse imaging, cells were maintained in CO2-independent medium
(Invitrogen) with 10% FBS.
Unless otherwise indicated, cells were incubated in 10 mM BI2536 (Thermo
Fisher Scientific) for 2.5 hr, although severely defective CENP-A deposition
was observed at concentrations down to at least 10 nM (Figure S2A). Where
indicated, cells were incubated with 5 mM flavopiridol (Sigma), 2 mM AZ3146
(Tocris), 10 mM 3MB-PP1 (Merck), or 10 mM S-trityl-L-cysteine (STLC) (Sigma)
for 1–2.5 hr. HeLa cells were synchronized by double thymidine block using
2 mM thymidine (Sigma) for all immunofluorescence and live-cell imaging
experiments unless otherwise stated.
Cell Line Generation and Transfection
The cell lines used in this study are described in Table S1. Clonal cell lines sta-
bly expressing GFPLAP or mCherryLAP fusions were generated in HeLa cells as
described previously (Cheeseman et al., 2004). Tetracycline-inducible cell
lines were generated using the Flp-In T-Rex Expression system (Invitrogen)
in a HeLa cell line (a gift from Stephen Taylor) and induced using 1 mg/ml
tetracycline (Sigma) approximately every 12 hr. Due to heterogeneity within(D) Left: schematic of M18BP1 showing residues phosphorylated by Plk1 in vitro
sufficient for M18BP1 centromere localization, Mis18a recruitment and CENP-A d
(E) Immunofluorescence images showing new CENP-A-SNAP deposition in cells
treatment with the described siRNAs. New CENP-A-SNAP is labeled using SNA
(F) Quantification of centromeric fluorescence intensity of new CENP-A-SNAP
M18BP1WT-NT or GFP-M18BP1Plk1-A-NT. Numbers are presented as a percentag
SEM; n = 20 G1 cell pairs. ***p < 0.001 (Student’s t test).
(G) Quantification of centromeric GFP-M18BP1WT-NT or GFP-M18BP1Plk1-A-NT fl
of GFP-M18BP1Plk1-A-NT is weak, even in the presence of the endogenous prote
(Student’s t test).
Scale bars, 5 mm. See also Figure S5.inducible cell lines, cells were matched for expression levels based on similar
fluorescence where appropriate and cells that lacked detectable fluorescence
were disregarded. The wild-type M18BP1 cDNA (Silva et al., 2012) was a gift
from Lars Jansen (Gulbenkian Institute for Science). E.-coli-optimized and
RNAi-resistant M18BP1, Mis18a, Mis18b, CENP-C, and corresponding phos-
phomutants were synthesized by Genewiz or generated using Quikchange
(Agilent). Point mutants are described in Table S2.
The Plk1 locus was tagged with eYFP at the C terminus using CRISPR/Cas-
mediated genome engineering in HeLa cells. The oligonucleotide sequences
introduced for the targeting site and to amplify the 50 and 30 homology arms
are listed in Table S3. Cas9 and single-guide RNA were expressed in pX330-
BFP (Cong et al., 2013; a gift fromChikdu Shivalila andRudolf Jaenisch,White-
head Institute/MIT) as described (Wang et al., 2013). The YFP donor plasmid
derived frompL452 (Liu et al., 2003)was agift fromPaul Fields andLaurieBoyer
(MIT). pX330 and the donor were cotransfected into HeLa cells at 2.5 mg each
and selected after 48 hr with 800 mg/ml G418 (Life Technologies) for 2 weeks.
Small interfering RNAs (siRNAs) (Table S4) and a nontargeting control were
obtained fromDharmacon. RNAi experiments were conducted using Lipofect-
amine RNAi MAX and serum-free OptiMEM (Invitrogen). DMEM plus 10% FBS
was added after 5 or 6 hr. Cells were assayed 48 hr after transfection. Transient
transfections were performed using Lipofectamine 2000 and OptiMEM
(Invitrogen) according to manufacturer’s instructions. The Premo FUCCI Cell
Cycle Sensor BacMam 2.0 (Invitrogen) was used according to manufacturer’s
instructions.
Immunofluorescence and Microscopy
Immunofluorescence was conducted using the antibodies listed in Table S5.
The pT702 phosphospecific antibody was generated against a synthesized
phosphopeptide with the following amino acid sequence: GTLEN(pT)
FEGHKSC (New England Peptide; Covance). Serum from the immunized rab-
bit was depleted against the unphosphorylated peptide and affinity purified
against the phosphorylated peptide. For immunofluorescence using the phos-
pho-specific antibody, cells were pre-extracted for 8–10 min in PBS plus 0.5%
Triton X-100 before fixation in 4% formaldehyde in PBS. Cy2-, Cy3-, and Cy5-
conjugated secondary antibodies were obtained from Jackson Laboratories.
DNA was visualized using 10 mg/ml Hoechst. G1 cells were identified by nu-
clear morphology (decondensed chromosomes) and microtubule staining:
either two daughter cells connected by a midbody or two daughter cells con-
nected by a microtubule pattern that is characteristic of cytokinesis failure
due to Plk1 inhibition (e.g., Figure 2A).
Immunofluorescence images were acquired on a DeltaVision Core
deconvolution microscope (Applied Precision) equipped with a CoolSnap
HQ2 charge-coupled device (CCD) camera and deconvolved where appro-
priate. For immunofluorescence, approximately ten Z sections were acquired
at 0.2 mm steps using a 1003/ 1.4 numerical aperture (NA) Olympus U-Pla-
nApo objective. In general, live-cell imaging was performed on the
DeltaVision microscope using a 603 /1.42 NA Olympus U-PlanApo objective.
For the initial characterization of localization (Figure 1A) and localization of
M18BP1 following CDK inhibition (Figures 3E and 3F), images were acquired
on a Nikon Ti-E inverted microscope with Perfect Focus system as part of
an Andor Revolution 500 XD laser system including a Yokogawa CSU-X1 spin-
ning disk confocal and Andor iXon 897 EMCCD camera using a 1003 /1.49 NA
Apo total internal reflection fluorescence (TIRF) objective. For live-cell imaging,
approximately four Z sections were acquired at 1 mm steps at 5–10 min. Right: schematic of an N-Terminal domain of M18BP1 (M18BP1-NT) that is
eposition. SANTA, SANT-associated domain; Myb, Myb DNA-binding domain.
expressing GFP fusions of either M18BP1WT-NT or M18BP1Plk1-A-NT following
P-Cell TMR-Star.
following replacement of endogenous M18BP1 with RNAi-resistant GFP-
e of the intensity inM18BP1WT-NT cells + control RNAi. The error bars represent
uorescence intensity in cells in which M18BP1 has been depleted. Localization
in (Figure S5G). The error bars represent SEM; n = 20 G1 cell pairs. **p < 0.005
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Figure 7. Model for the Control of CENP-A
Deposition by Plk1 and CDK
CENP-A deposition is accomplished by a two-step
regulatory mechanism integrating critical signals
from Plk1 and CDK. During S, G2, and M phases,
CDK inhibits Mis18 complex assembly. In G1, Plk1
at centromeres binds to and phosphorylates the
Mis18 complex to promote its localization and
license CENP-A deposition.intervals for 1 hr, with refocusing using differential interference contrast before
each time point. Images are scaled equivalently when shown for comparison,
unless otherwise stated. Quantification of fluorescence intensity was conduct-
ed on unprocessed images using Metamorph (Molecular Devices).
CENP-A-SNAP Labeling
SNAP quench-pulse labeling was performed as described (Jansen
et al., 2007) using a quench of 10 mM SNAP-Cell Block and a pulse of
either 3 mM SNAP-Cell TMR-Star or 5 mm SNAP-Cell Oregon Green (New
England Biosciences). To assay CENP-A deposition in G1, cells were ar-
rested in G1/S by double thymidine block and existing CENP-A-SNAP
was saturated with nonfluorescent SNAP-Cell Block. Cells were released
from the block for approximately 9 hr before addition of the fluorescent
SNAP substrate. SNAP-Cell Oregon Green and SNAP-Cell TMR-Star were
used as indicated in the figure legends. For RNAi experiments, cells
were fixed after approximately 11 hr. For BI2536 treatment, mitotic cells
were collected by mitotic shake off, split into two pools, and plated on poly-
lysine-coated coverslips. BI2536 was immediately added to one pool,
and an equivalent volume of DMSO was added to the other. The cells
were allowed to progress through G1 for 2–2.5 hr before fixation and
immunofluorescence.
To assay CENP-A deposition in S phase, cells were quenched and released
fromG1/S as above, allowed to progress for 5 hr before addition of the fluores-
cent SNAP substrate, and fixed at 6 hr after release. S phase cells were then
selected by punctate PCNA foci. To assay CENP-A deposition in G2 and M
phase, cells were allowed to progress for 8 hr before addition of the fluorescent
SNAP substrate. Cells were fixed at 9 hr (G2) or 10 hr (M) after release. G2 cells
were identified by high cytoplasmic cyclin B. Mitotic cells were identified by
DNA morphology or the presence of a mitotic spindle.
Protein Expression and Purification
GFPLAP-Mis18a was isolated from HeLa cells as described previously
(Cheeseman and Desai, 2005). To obtain cells in G1, cells were arrested over-Figure 6. Bypassing CDK and Plk1 Regulation Induces Cell-Cycle-Unc
(A) Immunofluorescence images showingGFP-Mis18a localization in cells transien
M18BP1CDK-A. Numbers represent centromeric fluorescence intensity as percent
(Student’s t test).
(B) Schematic of the cell synchronization and CENP-A-SNAP labeling strategy to
(C) Immunofluorescence images showing the presence or absence of new CENP-
expressing either mCherry-CENP-C-M18BP1CDK-A or mCherry-CENP-C-Mis18a
(D) Quantification of the percent of cells observed with new CENP-A-SNAP in ea
(E) Immunofluorescence images showing the recruitment of HJURP to centrome
tromeres are marked with anti-centromere antibodies. Numbers represent perce
n = 50 cells.
(F) Immunofluorescence images showing deposition of new CENP-A-SNAP (labe
Mis18a-expressing cells with BI2536. S phase cells are identified by punctate PC
centromeric new CENP-A-SNAP; n = 100 cells per condition.
(G) Immunofluorescence images summarizing mitotic defects observed in CENP
are marked with anti-centromere antibodies.
(H) Quantification of the percent of cells observed with the chromosome alignme
Scale bars, 5 mm. See also Figure S6.night in 20 nM nocodazole, collected by mitotic shake off, released by
washout, and harvested when centromeric localization of Mis18a was
observed for the majority of cells by microscopy. The asynchronous sample
was comprised of the cells that failed to arrest in nocodazole. The immuno-
precipitated proteins were identified by mass spectrometry of tryptic digests
using an LTQ XL Ion Trap mass spectrometer (Thermo Fisher Scientific)
coupled with a reverse phase gradient over C18 resin (Phenomenex). Data
were analyzed using SEQUEST software.
For recombinant expression of the Mis18 complex, E.-coli-optimized 6x-
His-Mis18a, E.-coli-optimized Mis18b, and human M18BP1 were cloned
into pST39 and expressed in Rosetta 2 (DE3)pLysS competent cells
(EMD Biosciences). The complex was bound to nickel NTA-agarose
(QIAGEN) in 50 mM sodium phosphate buffer (pH 8.0), 300 mM NaCl,
10 mM imidazole, and 0.1% Tween-20 and washed in 50 mM sodium
phosphate buffer (pH 8.0), 500 mM NaCl, 40 mM imidazole, and 0.1%
Tween-20. The complex was eluted in 50 mM sodium phosphate buffer
(pH 7.0), 500 mM NaCl, and 250 mM imidazole and exchanged into
20 mM HEPES (pH 7.5), 150 mM KCl, and 1 mM dithiothreitol (DTT). The
complex was analyzed by mass spectrometry to confirm the presence
of all three components. 6x-His-GST-PBD (residues 326–603) and the
6x-His-MBP-Plk1 T210D plasmid were gifts from Daniel Lim and Michael
Yaffe (MIT).
In Vitro Phosphorylation and Far-Western Analysis
Kinase assays were performed in 50mMHEPES (pH 7.5), 150mMKCl, 10 mM
MgCl2, 200 mMATP, and 1mMDTT at 33
C for 45min. For radioactive assays,
2 mCi g32P-ATP was added to each reaction. 6x-His-MBP-Plk1-T210D purified
from E. coli using Ni-NTA agarose (QIAGEN) was used for radioactive assays;
His-Plk1 (Invitrogen; generated by baculovirus expression) was used for
phosphosite mapping and far-western analysis. Phosphorylation by both of
these kinases was abrogated by the addition of BI2536 (data not shown).
Far-western analysis was performed as described using 6x-His-GST-PBD
(Lowery et al., 2007).oupled CENP-A Deposition
tly transfectedwith eithermCherry-CENP-C-M18BP1WT ormCherry-CENP-C-
of cells transfected with CENP-C-M18BP1CDK-A ± SEM; n = 20 cells; p < 0.001
detect the deposition of newly synthesized CENP-A in S, G2, and M phases.
A-SNAP (labeled with SNAP-Cell Oregon Green) at mitotic centromeres in cells
after 24 hr of induction of the fusion. Centromeres are marked with a-CENP-A.
ch cell cycle stage, 24 hr after induction of the fusion. nR 100 cells per stage.
res throughout the cell cycle, indicative of ongoing CENP-A deposition. Cen-
ntage of transfected cells in which GFP-HJURP was observed at centromeres;
led with SNAP-Cell Oregon Green) in S phase following treatment of CENP-C-
NA foci (data not shown). Numbers represent percent of cells showing robust
-C-Mis18a-expressing cells after 48 hr of induction of the fusion. Centromeres
nt phenotypes depicted in (G). n = 100 cells.
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